1.
Sholzberg M, Gwathmey K, Broome CM, Goebeler M, Murai H, Bata-Csörgo Z, Newland A, Ulrichts P, Kerstens R, Guptill JT, Agha S, Jiang M, Howard Jr JF. Overview of the Safety Profile From Efgartigimod Clinical Trials in Participants With Diverse IgG-Mediated Autoimmune Diseases. J of Skin [Internet]. 2024Jan.16 [cited 2024Jul.22];8(1):s344. Available from: https://jofskin.org/index.php/skin/article/view/2350